| CAS NO: | 1286279-29-5 |
| 规格: | 98% |
| 分子量: | 484.64 |
| 包装 | 价格(元) |
| 2mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Background:
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.
参考文献:
[1]. Norman P. et al. A dual CCR2/CCR5 chemokine antagonist, BMS-813160 Evaluation of WO2011046916. Expert Opin Ther Pat. 2011 Dec;21(12):1919-24.
m.cnreagent.com